References: Aspergillus infections, Construction and Renovation
Ruutu P, Valtonen V, Elonen E, Volin L, Tukiainen P, Ruutu T. Invasive pulmonary aspergillosis: a diagnostic and therapeutic problem. Clinical experience with eight haematologic patients. Scand J Infect Dis. 1987;19(5):569-75.
Ruutu P, Valtonen V, Tiitanen L, et al. An outbreak of invasive aspergillosis in a haematologic unit. Scand J Infect Dis. 1987;19(3):347-51.
Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev. 1996;9(4):499-511.
Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995;20(6):1526-30.
Pannuti C, Gingrich R, Pfaller MA, Kao C, Wenzel RP. Nosocomial pneumonia in patients having bone marrow transplant. Attributable mortality and risk factors. Cancer. 1992;69(11):2653-62.
Iwen PC, Reed EC, Armitage JO, et al. Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants [see comments]. Infect Control Hosp Epidemiol. 1993;14(3):131-9.
Saugier-Veber P, Devergie A, Sulahian A, et al. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: results of a 5 year retrospective study. Bone Marrow Transplant. 1993;12(2):121-4.
Schubert MM, Peterson DE, Meyers JD, Hackman R, Thomas ED. Head and neck aspergillosis in patients undergoing bone marrow transplantation. Report of four cases and review of the literature. Cancer. 1986;57(6):1092-6.
Landoy Z, Rotstein C, Shedd D. Aspergillosis of the nose and paranasal sinuses in neutropenic patients at an oncology center. Head Neck Surg. 1985;8(2):83-90.
Allo MD, Miller J, Townsend T, Tan C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med. 1987;317(18):1105-8.
Larkin JA, Greene JN, Sandin RL, Houston SH. Primary cutaneous aspergillosis: case report and review of the literature. Infect Control Hosp Epidemiol. 1996;17(6):365-6.
Johnson AS, Ranson M, Scarffe JH, Morgenstern GR, Shaw AJ, Oppenheim BA. Cutaneous infection with Rhizopus oryzae and Aspergillus niger following bone marrow transplantation. J Hosp Infect. 1993;25(4):293-6.
Gerson SL, Talbot GH, Lusk E, Hurwitz S, Strom BL, Cassileth PA. Invasive pulmonary aspergillosis in adult acute leukemia: clinical clues to its diagnosis. J Clin Oncol. 1985;3(8):1109-16.
Gerson SL, Talbot GH, Hurwitz S, Lusk EJ, Strom BL, Cassileth PA. Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med. 1985;79(1):57-64.
Wald A, van Burick JA, Leisenring W, al e. Bimodal incidence of invasive aspergillus (IA) after marrow transplant (MT): Implications for prevention strategies [abstract]. American Society of Microbiology. 1994:16.
McWhinney PH, Kibbler CC, Hamon MD, et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis. 1993;17(3):397-404.
Arnow PM, Sadigh M, Costas C, Weil D, Chudy R. Endemic and epidemic aspergillosis associated with in-hospital replication of Aspergillus organisms. J Infect Dis. 1991;164(5):998-1002.
Jandrlic M, Kalenic S, Labar B, et al. An autopsy study of systemic fungal infections in patients with hematologic malignancies. Eur J Clin Microbiol Infect Dis. 1995;14(9):768-74.
Choi SS, Milmoe GJ, Dinndorf PA, Quinones RR. Invasive Aspergillus sinusitis in pediatric bone marrow transplant patients. Evaluation and management. Arch Otolaryngol Head Neck Surg. 1995;121(10):1188-92.
Pannuti CS, Gingrich RD, Pfaller MA, Wenzel RP. Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. J Clin Oncol. 1991;9(1):77-84.
Offner F, Cordonnier C, Ljungman P, et al. Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis. 1998;26(5):1098-103.
Ribaud P, Chastang C, Latge JP, et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation [In Process Citation]. Clin Infect Dis. 1999;28(2):322-30.
Wingard JR, Beals SU, Santos GW, Merz WG, Saral R. Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplant. 1987;2(2):175-81.
Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984;100(3):345-51.
Weber SF, Peacock JE, Jr., Do KA, Cruz JM, Powell BL, Capizzi RL. Interaction of granulocytopenia and construction activity as risk factors for nosocomial invasive filamentous fungal disease in patients with hematologic disorders. Infect Control Hosp Epidemiol. 1990;11(5):235-42.
Aisner J, Schimpff SC, Bennett JE, Young VM, Wiernik PH. Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. Jama. 1976;235(4):411-12.
Lentino JR, Rosenkranz MA, Michaels JA, Kurup VP, Rose HD, Rytel MW. Nosocomial aspergillosis: A retrospective review of airi\borne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol. 1982;116(3):430-437.
Rotstein C, Cummings KM, Tidings J, et al. An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case-control study. Infect Control. 1985;6(9):347-55.
Opal SM, Asp AA, Cannady PB, Jr., Morse PL, Burton LJ, Hammer PGd. Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. J Infect Dis. 1986;153(3):634-7.
Perraud M, Piens MA, Nicoloyannis N, Girard P, Sepetjan M, Garin JP. Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works. Epidemiol Infect. 1987;99(2):407-12.
Weems JJ, Jr., Davis BJ, Tablan OC, Kaufman L, Martone WJ. Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy. Infect Control. 1987;8(2):71-5.
Barnes RA, Rogers TR. Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J Hosp Infect. 1989;14(2):89-94.
Hopkins CC, Weber DJ, Rubin RH. Invasive aspergillus infection: possible non-ward common source within the hospital environment. J Hosp Infect. 1989;13(1):19-25.
Flynn PM, Williams BG, Hetherington SV, Williams BF, Giannini MA, Pearson TA. Aspergillus terreus during hospital renovation [letter]. Infect Control Hosp Epidemiol. 1993;14(7):363-5.
Gerson SL, Parker P, Jacobs MR, Creger R, Lazarus HM. Aspergillosis due to carpet contamination [letter]. Infect Control Hosp Epidemiol. 1994;15(4 Pt 1):221-3.
Anderson K, Morris G, Kennedy H, et al. Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. Thorax. 1996;51(3):256-61.
Leenders A, van Belkum A, Janssen S, et al. Molecular epidemiology of apparent outbreak of invasive aspergillosis in a hematology ward. J Clin Microbiol. 1996;34(2):345-51.
Loo VG, Bertrand C, Dixon C, et al. Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol. 1996;17(6):360-4.
Rousey SR, Russler S, Gottlieb M, Ash RC. Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. Am J Med. 1991;91(5):484-92.
Perfect JR, Klotman ME, Gilbert CC, et al. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. J Infect Dis. 1992;165(5):891-7.
Tollemar J, Ringden O, Andersson S, et al. Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients. Transplant Proc. 1993;25(1 Pt 2):1495-7.
Goodrich JM, Mori M, Gleaves CA, et al. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. N Engl J Med. 1991;325(23):1601-7.
Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med. 1993;118(3):173-8.
Rhame FS, Striefel A, Stevens P, al. e. Endemic Aspergillus airbone spore levels are a major risk for aspergillosis in bone marrow transplant patients. 25th Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis Minnesota. 1985;Abstract 147.
Passweg JR, Rowlings PA, Atkinson KA, et al. Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia. Bone Marrow Transplant. 1998;21(12):1231-8.
Buckner CD, Clift RA, Sanders JE, et al. Protective environment for marrow transplant recipients: a prospective study. Ann Intern Med. 1978;89(6):893-901.
Petersen F, Thornquist M, Buckner C, et al. The effects of infection prevention regimens on early infectious complications in marrow transplant patients: a four arm randomized study. Infection. 1988;16(4):199-208.
Schimpff SC, Greene WH, Young VM, et al. Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis. Ann Intern Med. 1975;82(3):351-8.
Yates JW, Holland JF. A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients. Cancer. 1973;32(6):1490-8.
Bodey GP, Gehan EA, Freireich EJ, Frei Ed. Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia. Am J Med Sci. 1971;262(3):138-51.
Rhame FS. Nosocomial aspergillosis: how much protection for which patients? Infect Control Hosp Epidemiol. 1989;10(7):296-8.
Goodley JM, Clayton YM, Hay RJ. Environmental sampling for aspergilli during building construction on a hospital site. J Hosp Infect. 1994;26(1):27-35.
Streifel AJ, Lauer JL, Vesley D, Juni B, Rhame FS. Aspergillus fumigatus and other thermotolerant fungi generated by hospital building demolition. Appl Environ Microbiol. 1983;46(2):375-8.
Thio, C.L., D. Smith, W.G. Merz, et al., Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol, 2000. 21(1): p. 18-23.
